China's SFDA To Set Up System For New Drug Application, Approval And Appraisal
This article was originally published in PharmAsia News
Executive Summary
China's State FDA has released 44 drug databases to publicize all China-marketed drugs on its official website (http://www.sda.gov.cn/). The public can check 980,000 drug items, as well as medical devices and health products, for authenticity and effectiveness/functions, before making a purchase. The agency is also building the database for cosmetic products. Information on drug appraisal is now more transparent: companies that submit new drug applications can enquire online about the status during the drugs' prelaunch safety and efficacy appraisal process at the drug evaluation center website (http://www.cde.org.cn/). The major steps of new drug application, appraisal and approval have been fully divided to prevent unrestricted power that may lead to corruption and safety lapses. (Click here for more - Chinese Language)
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.